Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.04.18
内部控制审计报告
2014.04.18
2013年度募集资金存放与使用情况的专项报告
2014.04.18
第二届监事会第二十八次会议决议公告
2014.04.18
关于公司关联方占用上市公司资金情况的专项审核报告
2014.04.18
2013年度内部控制评价报告
2014.04.18
第二届董事会第三十一次会议决议公告
2014.04.18
关于召开2013年度股东大会的通知公告
2014.04.18
内部控制规则落实自查表
2014.04.18
独立董事候选人声明（张荣庆）
2014.04.18
关于使用自有闲置资金购买银行理财产品的公告
第一页
上一页
114
115
116
117
118
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
